Prelude Capital Management, LLC Eli Lilly & CO Put Options Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $117,469 - $127,776	1,100 New	1,100 $123,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $2.77 Million - $3.23 Million	-25,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $2.77 Million - $3.26 Million	24,900 Added 24900.0%	25,000 $3.24 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $10,590 - $11,864	100 New	100 $12,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.